Last reviewed · How we verify
98% aloe vera
98% aloe vera is a Small molecule drug developed by Beirut Arab University. It is currently FDA-approved.
At a glance
| Generic name | 98% aloe vera |
|---|---|
| Sponsor | Beirut Arab University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Flurbiprofen Versus Aloe Vera Gel in the Treatment of Chronic Periodontitis in Smoking Patients. (PHASE4)
- Comparison of the Effect of Gingival Massage of Aloe-vera Gel and Sidr Honey on Chronic Periodontitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 98% aloe vera CI brief — competitive landscape report
- 98% aloe vera updates RSS · CI watch RSS
- Beirut Arab University portfolio CI
Frequently asked questions about 98% aloe vera
What is 98% aloe vera?
98% aloe vera is a Small molecule drug developed by Beirut Arab University.
Who makes 98% aloe vera?
98% aloe vera is developed and marketed by Beirut Arab University (see full Beirut Arab University pipeline at /company/beirut-arab-university).
What development phase is 98% aloe vera in?
98% aloe vera is FDA-approved (marketed).
Related
- Manufacturer: Beirut Arab University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing